Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

Prostate Cancer Hormone Therapy Risky?

Study: Risks May Include Sudden Cardiac Death, Heart Attack, Heart Disease, Diabetes
WebMD Health News
Reviewed by Louise Chang, MD

Sept. 19, 2006 -- Hormone therapy for prostate cancer may make sudden death, heart attacks, coronary heart disease, and diabetes more likely, a new study shows.

More studies are needed to be sure of that. Meanwhile, men with prostatecancercancer and their doctors should weigh the risks and benefits of such treatment, say the researchers.

They included Nancy Keating, MD, MPH, of Harvard Medical School's health care policy department. Their study appears in the Journal of Clinical Oncology.

"This study shows that a common hormonal treatment for prostate cancer may put men at significant risk for other serious diseases," Keating says, in a Harvard news release.

"Patients and physicians need to be aware of the elevated risk as they make treatment decisions," Keating adds.

About the Study

Keating and colleagues checked medical records of more than 73,000 men enrolled in MedicareMedicare who were diagnosed with prostate cancer between 1992 and 1999.

The men were all at least 66 years old (average age: 74). They had local or regional prostate cancer, meaning their cancer hadn't spread far beyond the prostate.

Keating's team didn't assign the men to any particular treatment. Instead, the researchers simply noted the men's hormonal treatment.

A third of the men took hormonal drugs called gonadotropin-releasing hormone agonists (GnRH agonists such as Lupron and Zoladex) and 7% of the men had surgery to remove both of their testicles (bilateral orchiectomy).

At the study's start, more than 64,700 of the men didn't have diabetes and more than 59,700 didn't have coronary heart disease.

Follow-up Findings

The researchers followed the men for about 4.5 years, on average. During that time:

During the follow-up period, diabetesdiabetes was diagnosed in 11% of the men who didn't have diabetes when the study started.

Coronary heart diseaseheart disease was diagnosed in a quarter of the men who didn't have coronary heart disease when the study started.

Risk Higher With Hormone Therapy

During the study, men taking a GnRH agonist were 16% more likely to die from sudden cardiac death, 11% more likely to have a heart attack, 16% more likely to be diagnosed with coronary heart disease, and 44% more likely to be diagnosed with diabetes, compared to those with no treatment.

Today on WebMD

man with doctor
Symptoms, risks, treatments
man coughing
Men shouldn’t ignore
prostate cancer cells
What does this diagnosis mean?
doctor and male patient
Is it worth it?
cancer fighting foods
15 Cancer Symptoms Men Ignore
Prostate Enlarged
Picture Of The Prostate
Prostate Cancer Quiz
screening tests for men
Prostate Cancer Symptoms
Vitamin D